Molecular genetics analysis of hereditary breast and ovarian cancer patients in India
Authors:
- Nagasamy SoumittraNSNagasamy Soumittra
- Balaiah MeenakumariBMBalaiah Meenakumari
- Tithi ParijaTPTithi Parija
- Veluswami SrideviVSVeluswami Sridevi
- Karunakaran N NancyKNKarunakaran N Nancy
- Rajaraman SwaminathanRSRajaraman Swaminathan
- Kamalalayam R RajalekshmyKRKamalalayam R Rajalekshmy
- Urmila MajhiUMUrmila Majhi
- Thangarajan RajkumarTRThangarajan Rajkumar
Open Access
- 6 August 2009
- journal article
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 7 (1) , 13
Abstract
Background: Hereditary cancers account for 5–10% of cancers. In this study BRCA1, BRCA2 and CHEK2*(1100delC) were analyzed for mutations in 91 HBOC/HBC/HOC families and early onset breast and early onset ovarian cancer cases. Methods: PCR-DHPLC was used for mutation screening followed by DNA sequencing for identification and confirmation of mutations. Kaplan-Meier survival probabilities were computed for five-year survival data on Breast and Ovarian cancer cases separately, and differences were tested using the Log-rank test. Results: Fifteen (16%) pathogenic mutations (12 in BRCA1 and 3 in BRCA2), of which six were novel BRCA1 mutations were identified. None of the cases showed CHEK2*1100delC mutation. Many reported polymorphisms in the exonic and intronic regions of BRCA1 and BRCA2 were also seen. The mutation status and the polymorphisms were analyzed for association with the clinico-pathological features like age, stage, grade, histology, disease status, survival (overall and disease free) and with prognostic molecular markers (ER, PR, c-erbB2 and p53). Conclusion: The stage of the disease at diagnosis was the only statistically significant (p < 0.0035) prognostic parameter. The mutation frequency and the polymorphisms were similar to reports on other ethnic populations. The lack of association between the clinico-pathological variables, mutation status and the disease status is likely to be due to the small numbers.Keywords
This publication has 47 references indexed in Scilit:
- Identification of a novel CHEK2variant and assessment of its contribution to the risk of breast cancer in French Canadian womenBMC Cancer, 2008
- Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancerBreast Cancer Research, 2008
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancerBreast Cancer Research and Treatment, 2006
- SWISS-MODEL: an automated protein homology-modeling serverNucleic Acids Research, 2003
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- BRCA1 and BRCA2 in Indian breast cancer patientsHuman Mutation, 2002
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002
- SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modelingElectrophoresis, 1997
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995